Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online December 22, 2005
Stem Cells Vol. 24 No. 5 May 2006, pp. 1315 -1327
doi:10.1634/stemcells.2005-0029; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Table
Right arrow All Versions of this Article:
2005-0029v1
24/5/1315    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chute, J. P.
Right arrow Articles by Lin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chute, J. P.
Right arrow Articles by Lin, S.

THE STEM CELL NICHE

Molecular Profile and Partial Functional Analysis of Novel Endothelial Cell-Derived Growth Factors that Regulate Hematopoiesis

John P. Chutea, Garrett G. Muramotoa, Holly K. Dressmanb, Gary Wolfec, Nelson J. Chaoa, Simon Lind

a Division of Cellular Therapy, Department of Internal Medicine,
b Institute for Genome Sciences and Policy, Department of Molecular Genetics and Microbiology,
d Department of Bioinformatics and Biostatistics, Duke University, Durham, North Carolina, USA;
c Predictive Diagnostics Incorporated, Vacaville, California, USA

Key Words. Endothelial cell • Stem cell expansion • Hematopoietic stem cell

Correspondence: John P. Chute, M.D., Division of Cellular Therapy, Duke University, 2400 Pratt Street, Suite 1100, Box 3961, Durham, North Carolina 27710, USA. Telephone: 919-668-4706; Fax: 919-668-1091; e-mail: john.chute{at}duke.edu

Received January 21, 2005; accepted for publication December 14, 2005.
Recent progress has been made in the identification of the osteoblastic cellular niche for hematopoietic stem cells (HSCs) within the bone marrow (BM). Attempts to identify the soluble factors that regulate HSC self-renewal have been less successful. We have demonstrated that primary human brain endothelial cells (HUBECs) support the ex vivo amplification of primitive human BM and cord blood cells capable of repopulating non-obese diabetic/severe combined immunodeficient repopulating (SCID) mice (SCID repopulating cells [SRCs]). In this study, we sought to characterize the soluble hematopoietic activity produced by HUBECs and to identify the growth factors secreted by HUBECs that contribute to this HSC-supportive effect. Extended noncontact HUBEC cultures supported an eight-fold increase in SRCs when combined with thrombopoietin, stem cell factor, and Flt-3 ligand compared with input CD34+ cells or cytokines alone. Gene expression analysis of HUBEC biological replicates identified 65 differentially expressed, nonredundant transcripts without annotated hematopoietic activity. Gene ontology studies of the HUBEC transcriptome revealed a high concentration of genes encoding extracellular proteins with cell-cell signaling function. Functional analyses demonstrated that adrenomedullin, a vasodilatory hormone, synergized with stem cell factor and Flt-3 ligand to induce the proliferation of primitive human CD34+CD38lin cells and promoted the expansion of CD34+ progenitors in culture. These data demonstrate the potential of primary HUBECs as a reservoir for the discovery of novel secreted proteins that regulate human hematopoiesis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2006 by AlphaMed Press.